In vivo evaluation of porous hydroxyapatite/chitosan-alginate composite scaffolds for bone tissue engineering

Int J Biol Macromol. 2012 Dec;51(5):1079-85. doi: 10.1016/j.ijbiomac.2012.08.027. Epub 2012 Aug 30.

Abstract

Porous hydroxyapatite (HAp)/chitosan-alginate composite scaffolds were prepared through in situ co-precipitation and freeze-drying for bone tissue engineering. The composite scaffolds were highly porous and interconnected with a pore size of around 50-220 μm at low concentrations of HAp. As the HAp content increased, the porosity of the scaffolds decreased from 84.98 to 74.54%. An MTT assay indicates that the obtained scaffolds have no cytotoxic effects on MG-63 cells, and that they have good biocompatibility. An implantation experiment in mouse skulls revealed that the composite scaffold provides a strong positive effect on bone formation in vivo in mice. Furthermore, that HAp/chitosan-alginate composite scaffold has been shown to be more effective for new bone generation than chitosan-alginate scaffold.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alginates / metabolism*
  • Animals
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / metabolism
  • Biocompatible Materials / pharmacology*
  • Biocompatible Materials / toxicity
  • Bone and Bones / cytology*
  • Bone and Bones / physiology
  • Cell Line, Tumor
  • Chitosan / metabolism*
  • Durapatite / metabolism*
  • Freeze Drying
  • Glucuronic Acid / metabolism
  • Hexuronic Acids / metabolism
  • Humans
  • Mice
  • Osteogenesis / drug effects
  • Porosity
  • Tissue Engineering / methods*
  • Tissue Scaffolds*

Substances

  • Alginates
  • Biocompatible Materials
  • Hexuronic Acids
  • Glucuronic Acid
  • Chitosan
  • Durapatite